Core Insights - Molina (MOH) reported quarterly earnings of $6.01 per share, exceeding the Zacks Consensus Estimate of $5.96 per share, and up from $5.05 per share a year ago, representing an earnings surprise of 0.84% [1] - The company achieved revenues of $10.34 billion for the quarter ended September 2024, surpassing the Zacks Consensus Estimate by 3.80%, and up from $8.55 billion year-over-year [1] - Molina has consistently surpassed consensus EPS and revenue estimates over the last four quarters [1] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $5.89 on revenues of $10.15 billion, while for the current fiscal year, the estimate is $23.50 on revenues of $39.92 billion [4] - The estimate revisions trend for Molina is mixed, resulting in a Zacks Rank 3 (Hold), indicating expected performance in line with the market [4] Industry Context - The Medical - HMOs industry, to which Molina belongs, is currently ranked in the bottom 20% of over 250 Zacks industries, which may negatively impact stock performance [5] - Humana (HUM), another company in the same industry, is expected to report quarterly earnings of $3.48 per share, reflecting a year-over-year decline of 55.3%, with revenues projected at $28.66 billion, up 12.3% from the previous year [5]
Molina (MOH) Beats Q3 Earnings and Revenue Estimates